Is GoodRx Stock a Buy After the IPO?

Most of the IPO market struggled in early 2020 after the coronavirus hit. IPO activity fell by 48%, and proceeds form IPOs fell by 67% in April-March. Most business leaders did not trust the volatile public markets. However, as you would expect, healthcare IPOs were a special case. Probably due to the health scare, investors saw more opportunities in the healthcare market than anywhere else. The post Is GoodRx Stock a Buy After the IPO? appeared first on Money Morning - We Make Investing Profitable . But is GoodRx stock a buy after the IPO? To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.